Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
Stockhead TV
Tony’s Takeaway: A second helping of biotech picks
Health & Biotech
Health Check: Proteomics reports ‘excellent’ results for blood-based esophageal cancer test
Health & Biotech
Alive and Kicking: Kidney diagnosis house Proteomics divorces its US partner
Health & Biotech
ASX Health Stocks: Proteomics to start selling in France; Recce to start clinical trials
News
Market Highlights: Nasdaq can’t stop rallying, but ‘Goldilocks’ landing won’t be a sure thing for the ASX
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX health stocks: Proteomics tumbles 22pc on delayed product launch, Race hits 10mth highs
News
Top 10 at 10: AI, big gold hits, and a $65m cash windfall
News
Hot Money Monday: ‘Cut losses and let winners run’ – advice from legendary momentum trader Paul Tudor Jones
Health & Biotech
ASX Health Stocks: Neuren’s sales come in at top of guidance range, crushing short seller’s claims
News
Market Highlights: Bitcoin up again, Microsoft makes another huge AI bet, and 5 ASX small caps to watch
Health & Biotech
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
ScoPo’s Powerplays: Nanosonics ‘in the doghouse’, but ASX health stocks are largely being good boys
Health & Biotech
ScoPo’s Powerplays: ASX healthcare rises in Christmas rally as EBOS ups stake in Transmedic
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Health & Biotech
ASX Health Stocks: Neuren to start Phase 2 trial soon; Proteomics expands footprint in South America
Health & Biotech
